Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, CHF 0.01 par value per share
-
Shares outstanding
-
57,458,694
-
Total 13F shares
-
10,893,907
-
Share change
-
-112,033
-
Total reported value
-
$191,723,678
-
Price per share
-
$17.58
-
Number of holders
-
20
-
Value change
-
-$2,123,823
-
Number of buys
-
4
-
Number of sells
-
14
Institutional Holders of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) as of Q3 2025
As of 30 Sep 2025 Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,893,907 shares of stock of the company.
Largest 10 holders included EQT Fund Management S.a r.l., Pivotal bioVenture Partners Investment Advisor LLC, Aberdeen Group plc, Nan Fung Group Holdings Ltd, SR One Capital Management, LP, Alyeska Investment Group, L.P., ACUTA CAPITAL PARTNERS, LLC, Compagnie Lombard Odier SCmA, Woodline Partners LP, and UBS Group AG.
This table shows 20 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.